Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Search
Tuesday, November 5, 2024
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Resilinc Announces Chris Lanier as New Chief Technology Officer
SkySafe and Fortem Partner to Enhance Drone Detection and Mitigation
Cequence Security and AWS Team Up for Advanced API Protection and…
PCS Software Appoints Danielle Villegas as Chief Product Officer
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Home
Tags
Knight Therapeutics
Knight Therapeutics
Healthcare
Knight Therapeutics announces relaunch of AKYNZEO® in Brazil
Globe Newswire
-
July 5, 2022
Knight Therapeutics Inc., a pan-American (ex-USA) specialty pharmaceutical company, announced that its Brazilian affiliate, United Medical Ltd., is assuming full commercial activities and is...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
Resilinc Announces Chris Lanier as New Chief Technology Officer
SkySafe and Fortem Partner to Enhance Drone Detection and Mitigation
Cequence Security and AWS Team Up for Advanced API Protection and Bot Management
Load more
